Vascular endothelial growth factor gene therapy (ViroMed)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVascular endothelial growth factor gene therapy (ViroMed)
Drug Alias NameVMDA-3601
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionVascular endothelial growth factor A stimulants
TargetsVascular endothelial growth factor A
Therapy Area/IndicationsPeripheral Arterial Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDong-A Pharmaceutical Co LtdViromed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViromedDong-A Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsPeripheral Arterial Disease

Other Information

ATC CodeN/A
Related LinksN/A